rituximab-arrx

rituximab-arrx (RIABNI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

RIABNI is a marketed brand name for rituximab-arrx. Check FDA Drugs@FDA for the current US label holder and prescribing information.

rituximab-arrx has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.